Maxalt is a prescription medication used to treat acute migraine attacks in adults. It belongs to the neurology therapeutic class and contains the active ingredient rizatriptan. Maxalt is available as a pill in two strengths: 5 mg and 10 mg. In Hong Kong, Maxalt is regulated by the Department of Health and is dispensed only with a physician’s prescription. The product is marketed by Merck & Co., Inc.
Rizatriptan belongs to the triptan class of drugs, which work by targeting serotonin (5-hydroxytryptamine, 5-HT) receptors in the brain. Specifically, rizatriptan acts as an agonist at the 5-HT₁B and 5-HT₁D receptors:
These actions lead to a rapid reduction of migraine headache intensity, typically within 2 hours after the dose.
Maxalt is approved for the acute treatment of migraine attacks with or without aura in adult patients. It is not intended for migraine prevention or prophylaxis. The medication can be taken at the first sign of a migraine, and a second dose may be administered if the headache persists after two hours, provided the maximum daily dose is not exceeded.
Rizatriptan has been studied in limited clinical settings for cluster headache and short-lasting unilateral neuralgiform headache attacks (SUNHA). These investigations suggest potential benefit, but the uses remain off-label and are not approved by regulatory agencies in Hong Kong, the United States, or the European Union.
Disclaimer: Off-label use requires medical supervision and individualized risk assessment.
Absolute contraindications
History of coronary artery disease, angina, myocardial infarction, or other serious cardiovascular disorders.
Uncontrolled hypertension (systolic ≥ 160 mmHg or diastolic ≥ 100 mmHg).
Prior stroke, transient ischemic attack (TIA), or cerebral hemorrhage.
Hemiplegic or basilar migraine.
Severe hepatic impairment.
Known hypersensitivity to rizatriptan or any excipient in the tablet.
Relative contraindications
Age ≥ 65 years (use with caution and consider lower starting dose).
Moderate renal impairment (dose adjustment may be required).
Use of other serotonergic agents (e.g., SSRIs, SNRIs, MAO inhibitors) - increased risk of serotonin syndrome.
Pregnancy and lactation - rizatriptan is classified as Category C; benefits must outweigh potential risks.
This article provides educational information about Maxalt and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Maxalt should not be combined with other triptans or ergotamine derivatives within 24 hours because of the risk of excess vasoconstriction. If additional relief is needed, a non-triptan rescue medication such as a non-steroidal anti-inflammatory drug (NSAID) may be considered after consulting a healthcare professional.
Chest or throat tightness is a known side effect and should be evaluated promptly. If the sensation is mild and short-lasting, it may be monitored, but persistent or severe discomfort warrants immediate medical attention to rule out cardiovascular complications.
Maxalt can be taken at any time the migraine begins. Since migraine attacks are unpredictable, it is best to keep the tablet readily available and ingest it as early as possible after symptom onset.
Rizatriptan (Maxalt) generally has a faster onset of pain relief (often within 30 minutes) compared to some other triptans, and its half-life is slightly shorter, which may reduce the duration of side effects. However, individual response varies, and choice of triptan should be personalized by a clinician.
Yes, Maxalt is a prescription medication, so you should carry the original prescription label and a copy of the prescription. In Hong Kong, travelers may be asked to present a doctor's note; keep the medication in its original container to avoid customs issues.
The tablets contain lactose, microcrystalline cellulose, and magnesium stearate, among other excipients. Patients with severe lactose intolerance should discuss alternatives with their physician.
Rizatriptan does not have a direct effect on glucose metabolism. However, any medication that causes nausea or vomiting could indirectly influence blood sugar control, so diabetic patients should monitor their levels as usual.
St. John’s wort, a common serotonergic herb, may increase the risk of serotonin syndrome when taken with rizatriptan. Patients using herbal products should disclose them to their healthcare provider.
Store the tablets in a cool, dry place away from direct sunlight. If the indoor temperature frequently exceeds 30 °C, keep the medication in a cabinet or drawer rather than on a windowsill to maintain stability.
Yes, Maxalt can be effective for menstrual-related migraine attacks, provided the patient’s cardiovascular risk profile permits its use. Timing the dose at the onset of headache is critical for optimal relief.
